Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005047:Etoposide / Q000627:therapeutic use / Q000633:toxicity*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D011034:Podophyllotoxin